ALB and metabolic dysfunction-associated steatotic liver disease: It has already been suggested that individuals with NAFLD should be screened for CKD by eGFR and/or urinary albumin excretion even when classical risk factors for CKD are absent [17]; nevertheless, as hyperfiltration often precedes CKD, screening for an abnormally elevated eGFR could allow for an even earlier recognition of a possible risk.